First Successful Administration of LinearDNA via Lipid Nanoparticles
August 10th, 2022
Tag: LinearDNA
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
July 22nd, 2022
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
Spindle Biotech Research Collaboration on mRNA Production System
March 14th, 2022
Linea 1.0 COVID-19 Assay: Rapid Detection of Omicron Subvariant BA.2
January 28th, 2022
Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA
November 15th, 2021
Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing
November 9th, 2021